Overview
Currently, more than half of the global cancer burden occurs in low-and middle-income countries, with 40% of those cancers related to infection.
Listen in as Jordan discusses his labs' use of multiplexing technologies for multiple miRNA detections from crude matrices in a large number of samples as required for cancer screening.
Topics
The need for rapid and accurate identification of prognostic and diagnostic biomarkers for infection related cancers
Application of targeted and un-targeted technologies to miRNA biomarker discovery and their impact on downstream workflows integrating into a streamlined approach
Integrating field based approaches to miRNA development work early in your work for successful point of care